Speaker Profile
Ph.D., CEO, UCSF/Arc Isntitute
Biography
Matthew Nelson, Ph.D., is the founder and Chief Executive Officer of Genscience, an affiliate of Deerfield. He joined Deerfield in 2019 and continues to function as VP, Genetics & Genomics. Prior to Deerfield, he spent 15 years at GlaxoSmithKline and was most recently the Head of Genetics, Director of Biostatistics at Sequenom and Director of Genomics at Esperion Therapeutics. Dr. Nelson is an Adjunct Professor at the University of North Carolina and co-author on >80 publications, including several highly cited, field-leading works. He holds a Ph.D. in Human Genetics and an M.A. in Statistics from the University of Michigan.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures & Gad Getz, Broad Institute
PMWC Award Ceremony
• David Baker, University of Washington (Nobel Laureate, Luminary)
Featured Speakers
• David Baker, University of Washington
• Jack Dent, Chai Discovery
• Dimitri Yatsenko, DataJoint
• Evgeny Kiner, Neosplice Therapeutics
• Alex Morgan, Khosla Ventures
• Gad Getz, Broad Institute
Causal Targets, Not Just Better Molecules
Using AI and human biology to improve target selection before chemistry begins.
Data Is the Moat
What proprietary, longitudinal, and perturbational data really confer advantage.
From Prediction to Patient
Patient stratification, smarter trials, and the handoff from model to clinic.
Designed Biology Meets Drug Development
AI-designed proteins, developability, and what survives contact with reality.
The Target Discovery Bottleneck
Why splicing and other underused biology may expand what is druggable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
